These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36161584)

  • 21. Spongiform pemphigoid: A case series of an uncommon histopathologic pattern.
    Merton A; Wu YH
    J Cutan Pathol; 2020 Apr; 47(4):339-345. PubMed ID: 31837162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
    Domloge-Hultsch N; Utecht L; James W; Yancey KB
    Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bullous pemphigoid precipitated by PUVA therapy].
    Bastian P; Drobacheff C; Laurent R
    Ann Dermatol Venereol; 1990; 117(10):734. PubMed ID: 2073069
    [No Abstract]   [Full Text] [Related]  

  • 24. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
    Korman NJ; Stanley JR; Woodley DT
    Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers related to bullous pemphigoid activity and outcome.
    Giusti D; Le Jan S; Gatouillat G; Bernard P; Pham BN; Antonicelli F
    Exp Dermatol; 2017 Dec; 26(12):1240-1247. PubMed ID: 29105148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain.
    Lin MS; Fu CL; Giudice GJ; Olague-Marchan M; Lazaro AM; Stastny P; Diaz LA
    J Invest Dermatol; 2000 Dec; 115(6):955-61. PubMed ID: 11121125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood bullous pemphigoid: report of a case with life-threatening course during homeopathy treatment.
    Kuenzli S; Grimaître M; Krischer J; Saurat JH; Calza AM; Borradori L
    Pediatr Dermatol; 2004; 21(2):160-3. PubMed ID: 15078359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies.
    Leyendeckers H; Tasanen K; Bruckner-Tuderman L; Zillikens D; Sitaru C; Schmitz J; Hunzelmann N
    J Invest Dermatol; 2003 Mar; 120(3):372-8. PubMed ID: 12603849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease.
    Nätynki A; Tuusa J; Hervonen K; Kaukinen K; Lindgren O; Huilaja L; Kokkonen N; Salmi T; Tasanen K
    Front Immunol; 2020; 11():575805. PubMed ID: 33072118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: Dupilumab for the treatment of bullous pemphigoid.
    Wang M; Wang J; Shi B
    Dermatol Ther; 2022 Jul; 35(7):e15541. PubMed ID: 35478478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
    Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
    J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dupilumab for the treatment of nivolumab-induced bullous pemphigoid: a case report and review of the literature.
    Klepper EM; Robinson HN
    Dermatol Online J; 2021 Sep; 27(9):. PubMed ID: 34755978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bullous pemphigoid.
    Korman N
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):907-24. PubMed ID: 3294944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of IgE in autoimmunity.
    Sanjuan MA; Sagar D; Kolbeck R
    J Allergy Clin Immunol; 2016 Jun; 137(6):1651-1661. PubMed ID: 27264000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral pemphigoid autoantibodies preferentially target BP180 ectodomain.
    Calabresi V; Carrozzo M; Cozzani E; Arduino P; Bertolusso G; Tirone F; Parodi A; Zambruno G; Di Zenzo G
    Clin Immunol; 2007 Feb; 122(2):207-13. PubMed ID: 17141573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
    Kiss M; Husz S; Molnár K; Dobozy A
    Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.